The Black Market for Investigational GLP-1 Drugs
From JAMA Medical News · · 5 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content:
- Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain